Karyopharm Therapeut (KPTI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -196,039 | -93,841 | -60,714 | -23,462 | -76,422 |
| Depreciation Amortization | 10,432 | 7,977 | 5,093 | 2,415 | 4,205 |
| Accounts receivable | 4,588 | -1,111 | -2,166 | -4,477 | -3,804 |
| Accounts payable and accrued liabilities | -1,104 | 285 | -2,510 | 765 | 1,984 |
| Other Working Capital | 28,272 | 22,772 | 8,525 | -1,525 | -302 |
| Other Operating Activity | 78,482 | 377 | -5,909 | -12,700 | -53,147 |
| Operating Cash Flow | $-75,369 | $-63,541 | $-57,681 | $-38,984 | $-127,486 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | N/A | -142 |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -58,822 |
| Sale Of Investment | 43,378 | 38,378 | 33,573 | 15,288 | 154,437 |
| Investing Cash Flow | $43,378 | $38,378 | $33,573 | $15,288 | $95,473 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 27,250 | N/A | N/A | N/A | 83,300 |
| Debt Repayment | -250 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 9,511 | 356 | 356 | N/A | 1,452 |
| Other Financing Activity | -6,463 | 0 | 0 | 0 | -43,106 |
| Financing Cash Flow | $30,048 | $356 | $356 | $N/A | $41,646 |
| Exchange Rate Effect | 20 | 15 | 13 | 5 | -11 |
| Beginning Cash Position | 62,814 | 62,814 | 62,814 | 62,814 | 53,192 |
| End Cash Position | 60,891 | 38,022 | 39,075 | 39,123 | 62,814 |
| Net Cash Flow | $-1,923 | $-24,792 | $-23,739 | $-23,691 | $9,622 |
| Free Cash Flow | |||||
| Operating Cash Flow | -75,369 | -63,541 | -57,681 | -38,984 | -127,486 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -142 |
| Free Cash Flow | -75,369 | -63,541 | -57,681 | -38,984 | -127,628 |